InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 268918

Monday, 07/25/2016 7:26:42 AM

Monday, July 25, 2016 7:26:42 AM

Post# of 345704
http://www.tailwind.com/assets/20110104154949_4_NEWS.pdf
I will have to dig into all the prior posts regarding this because it certainly seems someone within Archway Marketing had some alliance with someone against Peregrine Pharmaceuticals and will ask Jim Hoch and Megan Effertz for starters

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News